Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy - Song_2023_Mol.Metab__101806 |
| Author(s) : Song Y , Yang H , Kim J , Lee Y , Kim SH , Do IG , Park CY |
| Ref : Mol Metab , :101806 , 2023 |
| Abstract : Song_2023_Mol.Metab__101806 |
| ESTHER : Song_2023_Mol.Metab__101806 |
| PubMedSearch : Song_2023_Mol.Metab__101806 |
| PubMedID: 37739179 |
| Title : Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension - Hong_2017_Diabetes.Obes.Metab_19_654 |
| Author(s) : Hong SM , Park CY , Hwang DM , Han KA , Lee CB , Chung CH , Yoon KH , Mok JO , Park KS , Park SW |
| Ref : Diabetes Obes Metab , 19 :654 , 2017 |
| Abstract : Hong_2017_Diabetes.Obes.Metab_19_654 |
| ESTHER : Hong_2017_Diabetes.Obes.Metab_19_654 |
| PubMedSearch : Hong_2017_Diabetes.Obes.Metab_19_654 |
| PubMedID: 28058750 |